The lancet. HIV
-
Randomized Controlled Trial Comparative Study
Efficacy and safety of switching to dolutegravir plus lamivudine versus continuing triple antiretroviral therapy in virologically suppressed adults with HIV at 48 weeks (DOLAM): a randomised non-inferiority trial.
Simplified antiretroviral therapy (ART) regimens are desirable for people with HIV. We investigated the efficacy and safety of switching from triple ART to dual dolutegravir plus lamivudine therapy. ⋯ Instituto de Salud Carlos III, Red de Investigación en Sida, and ViiV Healthcare.